Guangrong Lu

440 total citations
13 papers, 338 citations indexed

About

Guangrong Lu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Guangrong Lu has authored 13 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Guangrong Lu's work include Carbon and Quantum Dots Applications (2 papers), Cancer-related molecular mechanisms research (2 papers) and Selenium in Biological Systems (1 paper). Guangrong Lu is often cited by papers focused on Carbon and Quantum Dots Applications (2 papers), Cancer-related molecular mechanisms research (2 papers) and Selenium in Biological Systems (1 paper). Guangrong Lu collaborates with scholars based in China and United States. Guangrong Lu's co-authors include Preet M. Chaudhary, Vasu Punj, Rongrong Xie, Lili Li, Zijing Hu, Xiaojing Du, Yangyang Zhou, Cheng‐Yu Wu, Qiuxiang Chen and Shouxing Yang and has published in prestigious journals such as Chemical Engineering Journal, Molecules and Experimental Biology and Medicine.

In The Last Decade

Guangrong Lu

13 papers receiving 333 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Guangrong Lu China	11	225	107	91	61	30	13	338
Daniel L. Abravanel United States	5	210 0.9×	77 0.7×	166 1.8×	52 0.9×	29 1.0×	10	341
Guillaume Gapihan France	9	166 0.7×	118 1.1×	124 1.4×	48 0.8×	13 0.4×	13	298
Naixin Liang China	11	182 0.8×	147 1.4×	136 1.5×	68 1.1×	33 1.1×	13	352
Xueqiang Ding China	13	286 1.3×	157 1.5×	81 0.9×	35 0.6×	24 0.8×	16	384
Yingru Xu China	9	218 1.0×	119 1.1×	70 0.8×	33 0.5×	29 1.0×	20	322
Hirofumi Toi Japan	8	215 1.0×	73 0.7×	91 1.0×	69 1.1×	43 1.4×	17	372
Qinghua Xi China	12	197 0.9×	133 1.2×	64 0.7×	30 0.5×	49 1.6×	16	378
Elizabeth A. Loughran United States	7	202 0.9×	90 0.8×	132 1.5×	29 0.5×	29 1.0×	9	393

Countries citing papers authored by Guangrong Lu

Since Specialization

Citations

This map shows the geographic impact of Guangrong Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangrong Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangrong Lu more than expected).

Fields of papers citing papers by Guangrong Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guangrong Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangrong Lu. The network helps show where Guangrong Lu may publish in the future.

Co-authorship network of co-authors of Guangrong Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Guangrong Lu. A scholar is included among the top collaborators of Guangrong Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guangrong Lu. Guangrong Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Wang, Wenjing, Guangrong Lu, Zhichao Deng, et al.. (2024). Biocompatible carbon dots nanozymes as ROS/RNS modulators for ulcerative colitis alleviation by comprehensively orchestrating intestinal homeostasis. Chemical Engineering Journal. 502. 157800–157800. 11 indexed citations

Lu, Guangrong, et al.. (2023). A Ratiometric Fluorescent Sensor Based on Chelation-Enhanced Fluorescence of Carbon Dots for Zinc Ion Detection. Molecules. 28(23). 7818–7818. 11 indexed citations

Pan, Chenwei, Shaoxun Li, Zhihua Xu, et al.. (2021). Hybrid Nanoparticles Modified by Hyaluronic Acid Loading an HSP90 Inhibitor as a Novel Delivery System for Subcutaneous and Orthotopic Colon Cancer Therapy. International Journal of Nanomedicine. Volume 16. 1743–1755. 14 indexed citations

Ni, Leyi, Guangrong Lu, Lingling Zhou, et al.. (2021). IncRNA LUCAT1 acts as a Potential Biomarker and Demonstrates Malignant Biological Behaviors in Gastric Cancer. Clinical Laboratory. 67(08/2021). 2 indexed citations

Li, Lili, Rongrong Xie, & Guangrong Lu. (2021). Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma. Bioscience Reports. 41(6). 48 indexed citations

Zhou, Yangyang, Cheng‐Yu Wu, Guangrong Lu, et al.. (2020). FGF/FGFR signaling pathway involved resistance in various cancer types. Journal of Cancer. 11(8). 2000–2007. 80 indexed citations

Yang, Shouxing, et al.. (2019). Prognostic Value of Lymphovascular Invasion in Patients with Stage III Colorectal Cancer: A Retrospective Study. Medical Science Monitor. 25. 6043–6050. 34 indexed citations

Zheng, Bo, Lu Chen, Jianzhang Wang, et al.. (2018). Targeted Delivery of miRNA-204-5p By PEGylated Polymer Nanoparticles for Colon Cancer Therapy. Nanomedicine. 13(7). 769–785. 39 indexed citations

He, Yun, Shouxing Yang, Lingling Zhou, et al.. (2017). High expression of atonal homolog 8 predicts a poor clinical outcome in patients with colorectal cancer and contributes to tumor progression. Oncology Reports. 37(5). 2955–2963. 14 indexed citations

10.

He, Yun, Lingling Zhou, Yunfeng Shan, et al.. (2016). High Rab11-FIP4 expression predicts poor prognosis and exhibits tumor promotion in pancreatic cancer. International Journal of Oncology. 50(2). 396–404. 13 indexed citations

11.

Chen, Renpin, Zhiming Huang, Xiaohua Ye, et al.. (2014). Analysis of SEMA3B methylation and expression patterns in gastric cancer tissue and cell lines. Oncology Reports. 31(3). 1211–1218. 19 indexed citations

12.

Lu, Guangrong, Vasu Punj, & Preet M. Chaudhary. (2008). Proteasome inhibitor Bortezomib induces cell-cycle arrest and apoptosis in cell lines derived from Ewing’s sarcoma family of tumors and synergizes with TRAIL. Cancer Biology & Therapy. 7(4). 603–608. 50 indexed citations

13.

Berger, F. M., J. F. Douglas, Guangrong Lu, & B. J. Ludwig. (1969). Effect of N- -Phenylpropyl-N-benzyloxy Acetamide (W-1372) and of Clofibrate on the Lipids of Normal and Hypercholesteremia Rats. Experimental Biology and Medicine. 132(1). 293–297. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact